Fast Five Quiz: Scleroderma Systemic Sclerosis ILD Presentation and Diagnosis

Zab Mosenifar, MD

Disclosures

January 28, 2022

Goh and colleagues determined that extensive disease was a powerful predictor of mortality (hazard ratio 3.46, 95% confidence interval [CI] 2.19, 5.46). An SSc-ILD staging system, referred to as the Goh criteria, categorizes patients into two groups: those with limited disease (less than 30% disease extent on HRCT, or 10%-30% disease extent on HRCT and FVC 70% or greater predicted) and those with extensive disease (more than 30% disease extent on HRCT, or 10%-30% disease extent on HRCT and FVC less than  70% predicted).

Learn more about prognosis of CTD-ILD.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....